As a result, NAFDAC has issued a public service announcement asking people to avoid taking Miss Slim dietary supplements.
The agency’s Director-General, Prof. Moji Adeyeye, issued a public warning on Tuesday with the alert number 032/2021, informing the general public of the dangers in the country.
The FDA told the agency that “Palisades Park, NJ, HIS is voluntarily recalling all batches and all presentations of the goods,” according to the statement.
Due to undeclared Sibutramine being present in Miss Slim 10 and 30 count capsules, Palisades Park HIS has issued this voluntary recall.
It is an unapproved medication for whose safety and effectiveness have not been proven, and as a result, it is subject to a recall because of the inclusion of Sibutramine in Miss Slim.
“Products containing Sibutramine pose a threat to consumers because it is known to substantially increase blood pressure.
“Sibutramine may also present a significant risk for patients with a history of Coronary Artery Disease, Congestive Heart Failure, Arrhythmia or Stroke.“
The product is sold online at missslimusa.com,”
Consumers should avoid products containing Sibutramine since it has been shown to significantly raise blood pressure.
“Patients having a history of coronary artery disease, congestive heart failure, arrhythmia, or stroke may be more vulnerable to the side effects of sibutramine.”
The product may be purchased online at missslimusa.com, according to the notification.
As a result, NAFDAC pleaded with customers to cease buying and using Miss Slim, instructing them to “hand over to the closest NAFDAC office.”
Patients were also urged to contact their doctors or other healthcare professionals if they had any issues they suspected stemmed from taking the medication, according to the FDA.
It urged healthcare providers, customers, and patients to contact their local NAFDAC office if they had any side effects from using the product.
According to the statement, anybody who has a negative side effect should contact NAFDAC PRASCOR (20543 TOLL-FREE from all networks) or send an email to email@example.com immediately.
The general public is also encouraged to file a complaint via the NAFDAC website’s E-reporting platforms or the Med-safety app, which can be downloaded on both Android and IOS stores.